Brighter's Board of Directors has decided to initiate the process to apply for listing its shares on a regulated market.
At the board meeting on July 5th2018, the Board of Directors Brighter AB (publ) formally decided to initiate the process of applying for listing its shares on a regulated market. The listing is expected to take place in 2019.
"After a number of years focusing on product development, cooperation, partnerships and market preparation, Brighter has come to a phase in which the company's global ambitions are imminent. Listing the company’s shares on a regulated market opens up for new types of investors, such as institutional investors and international shareholders, while creating conditions for improved liquidity in the stock," says Barbro Fridén, Brighter’s Chairperson.
Earlier this year, the company adopted the IFRS accounting principle as a first step in the preparations for a main market listing, such as Nasdaq's Main Market.
"For the company's daily operations, in the interaction with partners and potential customers, it is also a significant seal of quality to be listed on a regulated market," says Truls Sjöstedt, Brighter's CEO and founder.
The company has initiated a pre-IPO process with PWC to conduct a review before an exchange auditor is appointed by the selected main market.
Brighter’s share has been traded on Nasdaq First North since 2014.
For more information, please contact:
Truls Sjöstedt, CEO
Telefon: +46 709 73 46 00
E-post: truls.sjostedt@brighter.se
Henrik Norström, COO
Telefon: +46 733 40 30 45
E-post: henrik.norstrom@brighter.se
About Brighter
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se
The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:30 CEST on July 6, 2018.